Assay for predicting the angiographic response to...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2317940

The present invention relates to an assay for testing the genetic predisposition to respond to lipid-lowering therapy in patients with coronary artery disease (CAD), comprising identifying the presence or absence of a TaqIB restriction site in intron 1 in both alleles of the cholesteryl ester transfer protein (CETP) gene by suitable molecular biological techniques; and correlating the presence of the restriction site on one or both alleles with a high or intermediate, susceptibility for lipid-lowering therapy. The invention further relates to a testkit for performing the assay and to a cholesterol ester transfer protein (CETP) gene marker for identifying individuals that may or may not be susceptible for lipid-lowering therapies.

La présente invention concerne un dosage permettant de tester la prédisposition génétique à réagir à un traitement hypolipidémiant de patients souffrant d'une maladie coronarienne. Ce dosage consiste à: déterminer la présence ou l'absence d'un site de restriction de TaqIb, dans l'intron1 des deux allèles du gène de la protéine de transfert de l'ester de cholestéryle, selon des techniques de biologie moléculaire appropriées; et à mettre en corrélation la présence du site de restriction se trouvant sur un allèle ou sur les deux allèles avec une sensibilité élevée ou moyenne vis-à-vis d'un traitement hypolipidémiant. Cette invention concerne également un nécessaire permettant de réaliser ce dosage et un gène marqueur de la protéine de transfert d'ester de cholestéryle permettant d'identifier les personnes qui peuvent ou ne peuvent pas réagir à des traitements hypolipidémiants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Assay for predicting the angiographic response to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Assay for predicting the angiographic response to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for predicting the angiographic response to... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1807436

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.